[Clinical study of the assimilation, tolerance and metabolic effectiveness of protein products combined with a soybean isolate].
Combined product containing soybean isolate 500E (produced by "Ralston Purine Company", USA) were clinically used in 16 patients with hyperlipidemia, type II. The results obtained evidenced a high assimilability (95.5-95.9%) and pronounced hupocholesterolemic effect of the soybean isolate when it was used as a substitute for 2/3 or 1/2 protein volume in the ration.
D000328:Adult; D004044:Dietary Proteins / Q000008:administration & dosage / Q000378:metabolism*; D004734:Energy Metabolism; D005527:Food, Fortified; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000178:diet therapy; D008297:Male; D008875:Middle Aged; D014674:Plant Proteins, Dietary / Q000008:administration & dosage / Q000378:metabolism*; D013025:Glycine max
D004044:Dietary Proteins; D014674:Plant Proteins, Dietary
Klinicheskoe izuchenie usvoiaemosti, perenosimosti i metabolicheskoĭ effektivnosti kombinirovannykh belkovykh produktov s izoliatom soi.